Atlas Trials

5-Azacytidine Prior to Allogeneic Stem Cell Transplant in High Risk Myelodysplastic Syndrome

Clinical trial NCT00721214 · COMPLETED

Trial details

NCT number
NCT00721214
Sponsor
Virginia Commonwealth University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Myelodysplastic Syndrome
Start date
2008-07-01
Primary completion
2014-06-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.